MyHealthTeam
MyHealthTeam | Posters
Swoop
Patient Reported Attitudes Towards Multiple Sclerosis Treatment
Background MS is a progressive disease that can have a devastating impact on quality of life. Yet obstacles exist for getting patients to start on or stay on a DMT to help slow progression. Understanding patient concerns and highlighting the benefits of DMTs can enable neurologists to help their patients overcome usage barriers. Objectives Research […]
Eric Peacock
The New Marketing Playbook: Engaging Patients in the Era of AI, Personalization, Patient Privacy, and Direct-to-Patient Offerings
At MyHealthTeam’s all-company get-together in Nashville, we invited five pharma marketing experts from top agencies and biotechs to join me on a panel. We discussed the “New Marketing Playbook” for everything from rare disease launches to direct-to-patient models to innovative uses of AI with patients.
Swoop
Zero Party and First Party Data Defined for Pharma Marketers
"Data is not created equally. Understanding the difference between zero-party and first-party data can be game-changing for pharma marketers. Below is a guide on how pharma marketers can reach more of the right people with less waste."
Eric Peacock
Top 5 Themes From Reuters Pharma USA: A Glimpse Into the Future of Pharma Marketing
"The Reuters Pharma USA conference, held this spring in Philadelphia, is one of the best conferences attended by and featuring pharma executives. Here are our notes on some of the top themes and actionable takeaways from the event."
MyHealthTeam | Posters
Swoop
Patient-Reported Health Inequities Among Breast Cancer Patients
Background Equal access to and quality of care are critical for creating positive outcomes for women living withbreast cancer. Despite increased awareness of health outcome disparities in the US, Black and Latina women still experience unique challenges in their breast cancer journey. Objectives To better understand potential disparities in healthcare quality, affordability, and access based […]
MyHealthTeam | Posters
Swoop
Patient Reported Impact of Psoriasis and Desired Treatment Outcomes
Background People living with psoriasis often struggle with its physical and mental health toll. Understanding the holistic impact of psoriasis is crucial to treating patients and enabling them to live more fulfilling lives. Objectives To understand the impact of psoriasis and desired treatment outcomes as well as ascertain patient awareness of the progressive nature of […]
Eric Peacock
4 Pharma Marketing Moves to Make in 2024; Turnkey tactics to make before third-party cookies go away
As the industry faces the depreciation of third-party cookies, pharma marketers and ad agencies are looking for new ways to effectively target diagnosed patients. Here are four tactics that can be launched in-market within a matter of weeks that allow brands to engage patients where they are – patient communities.
Eric Peacock
6 Takeaways From The Future of Digital Health Panel
Digital health media is on the precipice of major change. ChatGPT and AI are advancing faster than we ever thought they would. Third-party cookies are going away slower than we ever thought they would (finally happening next year). There’s a pressing case for improving health equity and patient privacy, and the pressured budgets of pharma companies looking to hedge against an uncertain economic and regulatory future weigh heavily in 2024 marketing plans.
Eric Peacock
Online Video Ads Reached Four Times as Many Diagnosed Patients at MyHealthTeam and Here’s Why
The average person watches 17 hours of online video each week, and video ads have nine times higher recall than print. But those great results only materialize when you can effectively target your online video ads to the types of people you want to reach.
Eric Peacock
Zero Party Data Defined in 30 Seconds and Why It Matters to Health Marketers
You may have heard the phrase “zero party data,” but you’re still wondering what it means. Zero party data is information a customer intentionally and proactively shares with a company, typically with the expectation that the company will use that information to deliver some sort of personalized value to the customer.